BioAsia 2025 gets overwhelming response from industries
Hyderabad: BioAsia 2025, Asia's largest life-sciences and healthcare conference, is set to provide a global platform for innovation and entrepreneurship and showcase startups as catalyst of future change.
As Asia’s premier life sciences event, BioAsia, hosted by the State government is poised to transform the entrepreneurial journey for startups within the healthcare and life sciences sectors by providing the right environment and ecosystem for growth.
The 'Innovation Zone' at BioAsia 2025 will be a dynamic hub showcasing the Startup Pavilion and the Incubator Pavilion, igniting innovation and unlocking investment opportunities. In line with BioAsia's ethos of fostering innovation, a select group of about 80 startups have earned coveted spots in the 22nd edition of this global conference to showcase their innovative solutions that have potential to transform healthcare globally.
In a unique and unparalleled opportunity, selected startups not only gain access to complimentary exhibition space but also unlock the doors to exclusive interactions with industry titans. This golden opportunity, exclusive to BioAsia, offers startups unprecedented access to invaluable mentorship, networking, and potential partnerships with global leaders in the life sciences and healthcare sectors.
It's an unparalleled chance to propel their innovations onto the world stage and accelerate their journey towards success. The response from industries to attend BioAsia 2025, which is a premier platform to showcase innovation in life sciences and healthcare, has been overwhelming.
The event has attracted interest from both national and international corporations, indicating a strong desire to engage with the latest innovations and developments in the life sciences and healthcare sectors. This enthusiastic response underscores the significance of BioAsia as a premier platform for industry collaboration, networking, and growth, providing start-ups with unparalleled opportunities for exposure, mentorship, and potential partnerships to accelerate their growth trajectory.
The line-up of startups set to grace BioAsia 2025 spans a diverse spectrum, from medical technology startups revolutionizing Drug Discovery Platforms to medical device startups solving for cancer screening, nasal septum, limb movements etc., Additionally, biotechnology startups are making strides in areas such as small molecule nanoparticles and novel drug candidates.
D Sridhar Babu, Minister for Industries and Commerce, IT E&C and Legislative Affairs, said “We are extremely excited with the response we have received from startups to participate in BioAsia 2025. Bio Asia is rightly poised as a global platform fostering innovation and collaboration within the life sciences and healthcare sectors. It is a great booster to the start-up ecosystem, with promising ventures showcasing their solutions to a global audience. As we witness enthusiastic engagement from both national and international startups, it reaffirms our commitment to positioning Telangana as a global leader in the field, empowering start-ups to thrive and innovate on a world stage.”
